Soft tissue sarcoma: Clinical practice guidelines in oncology™

George D. Demetri; Laurence H. Baker; Robert S. Benjamin; Ephraim S. Casper; Ernest U. Conrad; Gina Z. D'Amato; Thomas F. DeLaney; David S. Ettinger; Robert Heck; Martin J. Heslin; Ray J. Hutchinson; Charlotte D. Jacobs; Krystyna Kiel; William G. Kraybill; G. Douglas Letson; Richard J. O'Donnell; I. Benjamin Paz; John Pfeifer; Raphael E. Pollock; R. Lor Randall; Aaron R. Sasson; Karen D. Schupak; Douglas S. Tyler; Margaret Von Mehren; Jeffrey Wayne

doi:10.6004/jnccn.2007.0034

Soft tissue sarcoma: Clinical practice guidelines in oncology™

George D. Demetri, Laurence H. Baker, Robert S. Benjamin, Ephraim S. Casper, Ernest U. Conrad, Gina Z. D'Amato, Thomas F. DeLaney, David S. Ettinger, Robert Heck, Martin J. Heslin, Ray J. Hutchinson, Charlotte D. Jacobs, Krystyna Kiel, William G. Kraybill, G. Douglas Letson, Richard J. O'Donnell, I. Benjamin Paz, John Pfeifer, Raphael E. Pollock, R. Lor RandallAaron R. Sasson, Karen D. Schupak, Douglas S. Tyler, Margaret Von Mehren, Jeffrey Wayne

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

Soft tissue sarcomas are the most frequent sarcomas; the annual incidence for 2007 in the United States is estimated at about 9220 cases, with an overall mortality rate of approximately 3560 cases per year. Important updates for the 2007 version of the guidelines include the addition of epirubicin (single agent) and the combination of epirubicin, ifosfamide, and mesna as generally accepted systemic therapy. Imatinib was added as an option for desmoid tumors.

Original language	English (US)
Pages (from-to)	364-399
Number of pages	36
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	5
Issue number	4
DOIs	https://doi.org/10.6004/jnccn.2007.0034
State	Published - Apr 2007
Externally published	Yes

Keywords

Chemotherapy
Desmoid tumor
Gastrointestinal stromal tumors
NCCN Clinical Practice Guidelines
Radiation therapy
Retroperitoneal sarcomas
Soft tissue extremity sarcoma
Soft tissue sarcoma
Surgery

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2007.0034

Cite this

Demetri, G. D., Baker, L. H., Benjamin, R. S., Casper, E. S., Conrad, E. U., D'Amato, G. Z., DeLaney, T. F., Ettinger, D. S., Heck, R., Heslin, M. J., Hutchinson, R. J., Jacobs, C. D., Kiel, K., Kraybill, W. G., Letson, G. D., O'Donnell, R. J., Paz, I. B., Pfeifer, J., Pollock, R. E., ... Wayne, J. (2007). Soft tissue sarcoma: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 5(4), 364-399. https://doi.org/10.6004/jnccn.2007.0034

Demetri, GD, Baker, LH, Benjamin, RS, Casper, ES, Conrad, EU, D'Amato, GZ, DeLaney, TF, Ettinger, DS, Heck, R, Heslin, MJ, Hutchinson, RJ, Jacobs, CD, Kiel, K, Kraybill, WG, Letson, GD, O'Donnell, RJ, Paz, IB, Pfeifer, J, Pollock, RE, Randall, RL, Sasson, AR, Schupak, KD, Tyler, DS, Von Mehren, M & Wayne, J 2007, 'Soft tissue sarcoma: Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. 4, pp. 364-399. https://doi.org/10.6004/jnccn.2007.0034

@article{9be865e2b4a3409cab30a3c3415b7492,

title = "Soft tissue sarcoma: Clinical practice guidelines in oncology{\texttrademark}",

abstract = "Soft tissue sarcomas are the most frequent sarcomas; the annual incidence for 2007 in the United States is estimated at about 9220 cases, with an overall mortality rate of approximately 3560 cases per year. Important updates for the 2007 version of the guidelines include the addition of epirubicin (single agent) and the combination of epirubicin, ifosfamide, and mesna as generally accepted systemic therapy. Imatinib was added as an option for desmoid tumors.",

keywords = "Chemotherapy, Desmoid tumor, Gastrointestinal stromal tumors, NCCN Clinical Practice Guidelines, Radiation therapy, Retroperitoneal sarcomas, Soft tissue extremity sarcoma, Soft tissue sarcoma, Surgery",

author = "Demetri, {George D.} and Baker, {Laurence H.} and Benjamin, {Robert S.} and Casper, {Ephraim S.} and Conrad, {Ernest U.} and D'Amato, {Gina Z.} and DeLaney, {Thomas F.} and Ettinger, {David S.} and Robert Heck and Heslin, {Martin J.} and Hutchinson, {Ray J.} and Jacobs, {Charlotte D.} and Krystyna Kiel and Kraybill, {William G.} and Letson, {G. Douglas} and O'Donnell, {Richard J.} and Paz, {I. Benjamin} and John Pfeifer and Pollock, {Raphael E.} and Randall, {R. Lor} and Sasson, {Aaron R.} and Schupak, {Karen D.} and Tyler, {Douglas S.} and {Von Mehren}, Margaret and Jeffrey Wayne",

year = "2007",

month = apr,

doi = "10.6004/jnccn.2007.0034",

language = "English (US)",

volume = "5",

pages = "364--399",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "4",

}

TY - JOUR

T1 - Soft tissue sarcoma

T2 - Clinical practice guidelines in oncology™

AU - Demetri, George D.

AU - Baker, Laurence H.

AU - Benjamin, Robert S.

AU - Casper, Ephraim S.

AU - Conrad, Ernest U.

AU - D'Amato, Gina Z.

AU - DeLaney, Thomas F.

AU - Ettinger, David S.

AU - Heck, Robert

AU - Heslin, Martin J.

AU - Hutchinson, Ray J.

AU - Jacobs, Charlotte D.

AU - Kiel, Krystyna

AU - Kraybill, William G.

AU - Letson, G. Douglas

AU - O'Donnell, Richard J.

AU - Paz, I. Benjamin

AU - Pfeifer, John

AU - Pollock, Raphael E.

AU - Randall, R. Lor

AU - Sasson, Aaron R.

AU - Schupak, Karen D.

AU - Tyler, Douglas S.

AU - Von Mehren, Margaret

AU - Wayne, Jeffrey

PY - 2007/4

Y1 - 2007/4

N2 - Soft tissue sarcomas are the most frequent sarcomas; the annual incidence for 2007 in the United States is estimated at about 9220 cases, with an overall mortality rate of approximately 3560 cases per year. Important updates for the 2007 version of the guidelines include the addition of epirubicin (single agent) and the combination of epirubicin, ifosfamide, and mesna as generally accepted systemic therapy. Imatinib was added as an option for desmoid tumors.

AB - Soft tissue sarcomas are the most frequent sarcomas; the annual incidence for 2007 in the United States is estimated at about 9220 cases, with an overall mortality rate of approximately 3560 cases per year. Important updates for the 2007 version of the guidelines include the addition of epirubicin (single agent) and the combination of epirubicin, ifosfamide, and mesna as generally accepted systemic therapy. Imatinib was added as an option for desmoid tumors.

KW - Chemotherapy

KW - Desmoid tumor

KW - Gastrointestinal stromal tumors

KW - NCCN Clinical Practice Guidelines

KW - Radiation therapy

KW - Retroperitoneal sarcomas

KW - Soft tissue extremity sarcoma

KW - Soft tissue sarcoma

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=34248232454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248232454&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2007.0034

DO - 10.6004/jnccn.2007.0034

M3 - Article

C2 - 17442230

AN - SCOPUS:34248232454

SN - 1540-1405

VL - 5

SP - 364

EP - 399

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 4

ER -

Soft tissue sarcoma: Clinical practice guidelines in oncology™

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this